Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.
Ito S, Asahina H, Yamaguchi N, Tomaru U, Hasegawa T, Hatanaka Y, Hatanaka KC, Taguchi H, Harada T, Ohira H, Ikeda D, Mizugaki H, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Shinagawa N, Konno S. Ito S, et al. Among authors: mizugaki h. Respir Med Case Rep. 2021 Feb 18;32:101364. doi: 10.1016/j.rmcr.2021.101364. eCollection 2021. Respir Med Case Rep. 2021. PMID: 33665078 Free PMC article.
Expression of Bim, Noxa, and Puma in non-small cell lung cancer.
Sakakibara-Konishi J, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M. Sakakibara-Konishi J, et al. Among authors: mizugaki h. BMC Cancer. 2012 Jul 12;12:286. doi: 10.1186/1471-2407-12-286. BMC Cancer. 2012. PMID: 22788963 Free PMC article.
CD133 expression: a potential prognostic marker for non-small cell lung cancers.
Mizugaki H, Sakakibara-Konishi J, Kikuchi J, Moriya J, Hatanaka KC, Kikuchi E, Kinoshita I, Oizumi S, Dosaka-Akita H, Matsuno Y, Nishimura M. Mizugaki H, et al. Int J Clin Oncol. 2014 Apr;19(2):254-9. doi: 10.1007/s10147-013-0541-x. Epub 2013 Mar 12. Int J Clin Oncol. 2014. PMID: 23479121
Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage.
Shoji T, Mizugaki H, Ikezawa Y, Furuta M, Takashima Y, Kikuchi H, Goudarzi H, Asahina H, Kikuchi J, Kikuchi E, Sakakibara-Konishi J, Shinagawa N, Tsujino I, Nishimura M. Shoji T, et al. Among authors: mizugaki h. Intern Med. 2018 Jun 15;57(12):1769-1772. doi: 10.2169/internalmedicine.9741-17. Epub 2018 Feb 9. Intern Med. 2018. PMID: 29434159 Free PMC article.
Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
Ikari T, Sakakibara-Konishi J, Yamamoto G, Kitai H, Mizugaki H, Asahina H, Kikuchi E, Shinagawa N. Ikari T, et al. Among authors: mizugaki h. Clin Lung Cancer. 2019 Jul;20(4):e531-e533. doi: 10.1016/j.cllc.2019.05.002. Epub 2019 May 11. Clin Lung Cancer. 2019. PMID: 31164318 No abstract available.
40 results